Taro Pharmaceuticals Announced Recall for Phenytoin
WASHINGTON, D.C. — The U.S. Food and Drug Administration, or FDA, along with Taro Pharmaceuticals U.S.A., announced a voluntary recall for Phenytoin Oral Suspension USP, in the dose of 125 mg/5 ml because of the potential patients will receive an insufficient dose or could overdose. Taro recalled two lots of the drug, both of which … [Read more...] about Taro Pharmaceuticals Announced Recall for Phenytoin
Cerebellar Atrophy Reported in Dilantin Patients
The U.S. Food and Drug Administration (FDA) has approved labeling changes stating that cerebellar atrophy has been reported in patients taking phenytoin. This nervous system adverse reaction appears to occur more frequently when drug levels are elevated or when it is used long-term. Phenytoin is sold by Pfizer under the brand name … [Read more...] about Cerebellar Atrophy Reported in Dilantin Patients
Suit Over Phenytoin Names 10 Defendants in Womans Death
Agnes Davis was Prescribed Phenytoin and Suffered a Severe Adverse Reaction SJS. According to court papers, Agnes Davis was prescribed phenytoin and then suffered a severe adverse reaction- Stevens-Johnson Syndrome - that allegedly led to her death. Phenytoin is a generic version of Dilantin. The lawsuit, filed by Willie Davis Jr. … [Read more...] about Suit Over Phenytoin Names 10 Defendants in Womans Death
